BARDA Proposes New Consortia For Rapid Pandemic Response
The HHS agency hopes to bring together private sector teams that could quickly defend the US against future infectious outbreaks. The plan also calls for working with commercial lenders for the capital required to expand production of medical countermeasures.
You may also be interested in...
The Biomedical Advanced Research and Development Authority says lessons learned from the pandemic has better prepared the agency to respond to future health emergencies, including a new infectious disease division.
Some filling lines and API plants fared poorly in post-pandemic inspections, with shortfalls identified in sterility assurance and impurity control. Zhejiang Tianyu and System Kosmetik got warning letters. Alvotech, Cipla and Aurobindo got Form 483 reports posted on the FDA website.
Responses to FDA draft guidance suggest more promptness while also more elaborate processes for agency decision making based on remote methods. Questions include what’s voluntary, what’s mandatory, what can be decided remotely, and how to remotely move on from warning letters.